StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research note released on Tuesday. The brokerage issued a hold rating on the medical device company’s stock.
Avinger Price Performance
Shares of NASDAQ AVGR opened at $1.01 on Tuesday. The firm has a market cap of $1.72 million, a price-to-earnings ratio of -0.06 and a beta of 1.17. The stock’s fifty day moving average price is $1.13 and its two-hundred day moving average price is $2.16. Avinger has a one year low of $0.90 and a one year high of $6.55.
Avinger (NASDAQ:AVGR – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The company had revenue of $1.85 million for the quarter, compared to analyst estimates of $2.55 million. On average, equities analysts anticipate that Avinger will post -4.69 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Avinger
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Recommended Stories
- Five stocks we like better than Avinger
- What Do S&P 500 Stocks Tell Investors About the Market?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.